|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q92816415
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241120235835.0 |
|
008
|
|
|
241120nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q92816415
|
|
024
|
|
|
‡a
0000-0001-8198-9161
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q92816415
|
|
100
|
0 |
|
‡a
Reynaldo Oliva
‡c
researcher (ORCID 0000-0001-8198-9161)
‡9
en
|
|
400
|
0 |
|
‡a
Reynaldo Oliva
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routes
|
|
909
|
|
|
‡a
(orcid) 0000000181989161
‡9
1
|
|
919
|
|
|
‡a
assessingtheimmunogenicityandtoxicityoftheafpl1conjugatenicotinevaccineusingheterologousandhomologousvaccinationroutes
‡A
Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routes
‡9
1
|
|
996
|
|
|
‡2
BNCHL|10000000000000000141293
|
|
996
|
|
|
‡2
BIBSYS|4058115
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
